Cases
CourtFilingsPetition dateMore filters
The court denied Oxford Finance LLC’s request to stay dismissal of its adversary complaint pending appeal, but imposed a 30-day administrative stay measured from the June 29 hearing. During that period, the Plan Administrator, Redwood and related parties cannot distribute, transfer or dissipate the disputed malpractice settlement proceeds, which must remain escrowed or segregated. The stay terminates automatically if Oxford misses its appeal deadline and otherwise expires after 30 days unless the bankruptcy court or district court extends it, according to the order denying Oxford’s stay motion.
Oxford, Genapsys’ former senior secured lender, claims ownership of the proceeds through assets acquired following its foreclosure on Sequencing. Its five-count complaint challenged the Plan Administrator’s authority to distribute those proceeds after Redwood settled malpractice claims against Genapsys’ former corporate counsel. The ruling preserves the disputed fund only temporarily while Oxford seeks appellate relief; absent an extension, the Plan Administrator will regain access to proceeds otherwise intended for creditor and equity distributions.
GenapSys, Inc. filed Chapter 11 in Delaware on July 11, 2022, with estimated assets and liabilities each in the $10 million to $50 million range and 200 to 999 creditors. The Redwood City life sciences debtor developed semiconductor-based DNA sequencing technology, and CFO Britton Russell signed the petition after the board authorized a Chapter 11 filing, DIP financing, and a section 363 sale process source filing source filing.
The case opened after a liquidity crisis and shareholder litigation over the company’s capital stack. Russell described roughly $230.3 million of secured debt and preferred equity, including a $30 million Oxford Finance term loan, $200.3 million of preferred equity liquidation preferences, and about $4 million of unsecured claims; Foresite Capital also had pending litigation tied to a $50 million Series C investment. By the petition date, GenapSys had furloughed nearly all employees on June 24 and laid off or further furloughed more than 70 employees on July 8 source filing.
The initial case strategy was an accelerated financing-backed sale, not an operating reorganization. Oxford proposed a $4 million DIP facility, with $1 million available on an interim basis, alongside access to $3 million of restricted cash as cash collateral; the debtor separately moved to sell substantially all assets, with a proposed August 23 bid deadline and DIP-linked milestones requiring sale approval within 54 days and closing within 60 days of the petition date source filing source filing.
Loading defined terms…